Abstract
Phenotyping of major depressive disorder (MDD) in research can vary from study to study, which, together with heterogeneity of the disorder, may contribute to the inconsistent associations with various risk factors including neuroimaging features. These aspects also potentially underlie previous problems with machine learning methods using imaging data to inform predictive biomarkers. In this study we therefore aimed to examine the classification accuracy of structural and functional connectomes across different depressive phenotypes, including separating MDD subgroups into those with and without early childhood adversity (one of the largest risk factors for MDD associated with brain development). We applied logistic ridge regression to classify control and MDD participants defined according to six different MDD definitions in a large community-based sample (N = 14, 507). We used brain connectomic data based on six structural and two functional network weightings and conducted a comprehensive analysis to (i) explore how well different connectome modalities predict different MDD phenotypes commonly used in research, (ii) investigate whether stratification of MDD based on the presence or absence of early childhood adversity (measured with the childhood trauma questionnaire) can improve prediction accuracies, and (iii) identify important predictive features that are consistent across MDD phenotypes. We find that functional connectomes consistently outperform structural connectomes as features for MDD classification across phenotypes. Highest accuracy of 61.06% (chance level 50.0%) was achieved when predicting the Currently Depressed phenotype (i.e. the phenotype defined by the presence of more than five symptoms of depression in the past two weeks) with features based on partial correlation functional connectomes. Accuracy of classifying Currently Depressed participants with added CTQ threshold criterion rose to 65.74%. Application of the Jaccard index to assess predictive feature overlap indicated that there were neurobiological differences between MDD patients with and without childhood adversity. Further to that, analysis of predictive features for different MDD phenotypes with binomial tests revealed sensorimotor and visual functional subnetworks as consistently important for prediction. Our results provide the basis for future research, and indicate that differences in sensorimotor and visual subnetworks may serve as important biomarkers of MDD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is supported by Wellcome Trust awards (References 104036/Z/14/Z; 220857/Z/20/Z), and was also supported by National Institutes of Health (NIH) research grant R01AG054628 which supported CRB, EMTD, MEB and SRC. The research was conducted using the UK Biobank resource, with approved project number 10279 and 4844. Structural brain imaging data from UK Biobank was processed using facilities within the Lothian Birth Cohort group at the University of Edinburgh, which is supported by Age UK (as The Disconnected Mind project), the Medical Research Council (MR/R024065/1), and the University of Edinburgh. This work has made use of the resources provided by the Edinburgh Compute and Data Facility (ECDF). The Population Research Center (PRC) and Center on Aging and Population Sciences (CAPS) at The University of Texas at Austin are supported by National Institutes of Health (NIH) grants P2CHD042849 and P30AG066614, respectively. HWY is supported by the endowments to the Division of Division of Psychiatry, University of Edinburgh. GT is supported by supported by the Agency of Science, Technology and Research (A*STAR) in Singapore. KMS was supported by Health Data Research UK, an initiative funded by UK Research and Innovation Councils, NIH Research (England) and the UK devolved administrations, and leading medical research charities. SRC is also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (221890/Z/20/Z). AMM and HCW are additionally supported by a UKRI award (Reference MC\_PC\_17209).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The UK Biobank's Access Procedures stipulate that participant data can only be made available to approved researchers. Therefore, the data used in this study cannot be made available for public access.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* These authors share joint senior authorship
Data Availability
The UK Biobank's Access Procedures stipulate that participant data can only be made available to approved researchers. Therefore, the data used in this study cannot be made available for public access.
